Skip to content
DataLookout
Menu

NCT07938866

Genomic Predictors of Response to CAR-T and BiTE Therapies in B-cell Non-Hodgkin Lymphomas

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Number of participants who achieve complete remission (CR) following CAR-T therapy
Timeframe: From enrollment to 360 days after CAR-T/BiTE therapy

Secondary (1)

Number of participants with progression-free survival (PFS) at 1 year

Arms and interventions

Registry Patients

Patients with relapsed or refractory B-cell non-Hodgkin lymphoma (R/R NHL)